BioCentury | Dec 10, 2019
Finance

Perceptive launches $210M early-stage fund tied to Garabedian’s accelerator Xontogeny

...”). PXV closed earlier this week, but it has already invested in two therapeutics companies: Quellis Biosciences Inc....
...and VP of corporate development at Gilead Sciences Inc. (NASDAQ:GILD). Val Kennedy, Associate Editor Perceptive Advisors Landos Biopharma Inc. Quellis Biosciences Inc....
Items per page:
1 - 1 of 1
BioCentury | Dec 10, 2019
Finance

Perceptive launches $210M early-stage fund tied to Garabedian’s accelerator Xontogeny

...”). PXV closed earlier this week, but it has already invested in two therapeutics companies: Quellis Biosciences Inc....
...and VP of corporate development at Gilead Sciences Inc. (NASDAQ:GILD). Val Kennedy, Associate Editor Perceptive Advisors Landos Biopharma Inc. Quellis Biosciences Inc....
Items per page:
1 - 1 of 1